Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Markham

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Targeted Oncology|February 17, 2022
Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell CarcinomaAnthony Markham
Drugs|October 5, 2018
Correction to: Delafloxacin: First Global ApprovalAnthony Markham
Drugs|October 28, 2021
Avatrombopag: A Review in ThrombocytopeniaAnthony Markham
Drugs|October 28, 2021
Zimberelimab: First ApprovalAnthony Markham
Drugs|March 29, 2022
Gefapixant: First ApprovalAnthony Markham
Drugs|June 5, 2019
Erdafitinib: First Global ApprovalAnthony Markham
Drugs|July 1, 2019
Alpelisib: First Global ApprovalAnthony Markham
Drugs|May 18, 2021
Evinacumab: First ApprovalAnthony Markham
Drugs|September 5, 2014
Idelalisib: first global approvalAnthony Markham
Drugs|December 15, 2020
Enarodustat: First ApprovalAnthony Markham
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Targeted Oncology|February 17, 2022
Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell CarcinomaAnthony Markham
Drugs|October 5, 2018
Correction to: Delafloxacin: First Global ApprovalAnthony Markham
Drugs|October 28, 2021
Avatrombopag: A Review in ThrombocytopeniaAnthony Markham
Drugs|October 28, 2021
Zimberelimab: First ApprovalAnthony Markham
Drugs|March 29, 2022
Gefapixant: First ApprovalAnthony Markham
Drugs|June 5, 2019
Erdafitinib: First Global ApprovalAnthony Markham
Drugs|July 1, 2019
Alpelisib: First Global ApprovalAnthony Markham
Drugs|May 18, 2021
Evinacumab: First ApprovalAnthony Markham
Drugs|September 5, 2014
Idelalisib: first global approvalAnthony Markham
Drugs|December 15, 2020
Enarodustat: First ApprovalAnthony Markham
Pageof 9